e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Asthma: new mechanisms and markers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LSC 2013 abstract - Activin-A is up-regulated in severe asthma and is associated with angiogenesis
K. Samitas, N. Poulos, E. Zervas, M. Semitekolou, H. Kariyawasam, V. Panoutsakopoulou, Y. Sun, C. Corrigan, G. Xanthou, M. Gaga (Athens, Greece; London, United Kingdom)
Source:
Annual Congress 2013 –Asthma: new mechanisms and markers
Session:
Asthma: new mechanisms and markers
Session type:
Thematic Poster Session
Number:
592
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Samitas, N. Poulos, E. Zervas, M. Semitekolou, H. Kariyawasam, V. Panoutsakopoulou, Y. Sun, C. Corrigan, G. Xanthou, M. Gaga (Athens, Greece; London, United Kingdom). LSC 2013 abstract - Activin-A is up-regulated in severe asthma and is associated with angiogenesis. Eur Respir J 2013; 42: Suppl. 57, 592
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
LSC 2013 abstract - Abnormal neutrophil migration is a feature of early COPD, present across disease phenotypes and causally related to increased phosphoinositide-3-kinase signalling
Source: Annual Congress 2013 –Molecular biology: state-of-the-art 2013
Year: 2013
Activin-A expression is increased in severe asthma and is involved in tissue angiogenesis
Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms
Year: 2012
LSC 2013 abstract - Mechanisms regulating enhanced alphavbeta6 expression in pulmonary fibrosis
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013
Activin-A is overexpressed in severe asthma and is implicated in angiogenic processes
Source: Eur Respir J 2016; 47: 769-782
Year: 2016
LSC 2013 abstract - Unravelling VEGF165 signalling in the lung
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013
LSC 2010 Abstract: TNFα promoter polymorphism is associated with increased local production and enhanced downstream inflammation in COPD
Source: Annual Congress 2010 - New mechanisms in lung development, acute and chronic lung diseases
Year: 2010
LSC 2013 abstract - Prominence of MMP-12 and MMP-13 in dendritic cells and the impact on a murine model of bronchiolitis obliterans
Source: Annual Congress 2013 –New insights into mechanisms of lung allograft dysfunction
Year: 2013
LSC 2013 abstract - MicroRNA based biomarkers for early risk assessment of asthma
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013
LSC 2013 abstract - Bioavailability of VEGF in idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013
Genes affecting mRNA stability and metalloproteinase inhibitor RECK are down-regulated in patients with COPD
Source: Annual Congress 2013 –New insights into epigenetic mechanisms in the lung
Year: 2013
LSC 2013 abstract - Role of CXCL13 in cigarette smoke-induced lymphoid follicle formation and COPD
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
Sputum cell mRNA transcripts demonstrate alteration of endothelin metabolism in severe asthma and COPD
Source: Annual Congress 2013 –New drugs in respiratory medicine
Year: 2013
LATE-BREAKING ABSTRACT: Defect of HDAC7 causes impaired VEGF expression in response to hypoxia in COPD
Source: Annual Congress 2013 –New insights into epigenetic mechanisms in the lung
Year: 2013
LSC 2013 abstract - Identifying a molecular defect in bronchial epithelial cells from 70% of mild asthmatics
Source: Annual Congress 2013 –New insights into epigenetic mechanisms in the lung
Year: 2013
LSC 2013 abstract - NF-κbeta acts downstream of EGFR in regulating low dose cadmium induced primary lung cell proliferation
Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013?
Year: 2013
LSC 2013 abstract - ST13 and ORMDL3 polymorphisms affect the risk of exacerbations in steroid-treated asthmatic children and young adults
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013
Mast cell gene signature enrichment associates with late-onset severe asthma
Source: International Congress 2016 – Phenotyping asthma
Year: 2016
Late Breaking Abstract - ACE2 expression in lower airway epithelial cells is increased with age and in males, but is less in asthma.
Source: Virtual Congress 2020 – Covering COVID - the best abstracts
Year: 2020
Benralizumab restored expression of key molecules involved in steroid-resistance in patients with severe asthma
Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights
Year: 2020
LSC - 2019 - Unraveling the role of miR-223-3p in the regulation of airway inflammation in asthma and COPD
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept